ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Anti-Obesity Effect and Mechanism of Chitooligosaccharides Were Revealed Based on Lipidomics in Diet-Induced Obese Mice

Zhou, Minchuan; Huang, Jingqing; Zhou, Jingwen; Zhi, Cuiting; Bai, Yan; Che, Qishi; Cao, Hua; Guo, Jiao*; Su, Zhengquan*广东药学院
MOLECULES2023-7DOI: 10.3390/molecules28145595
15阅读
引用收藏
分享

摘要

Chitooligosaccharide (COS) is a natural product from the ocean, and while many studies have reported its important role in metabolic diseases, no study has systematically elaborated the anti-obesity effect and mechanism of COS. Herein, COSM (MW & LE; 3000 Da) was administered to diet-induced obese mice by oral gavage once daily for eight weeks. The results show that COSM administration reduced body weight; slowed weight gain; reduced serum Glu, insulin, NEFA, TC, TG, and LDL-C levels; increased serum HSL and HDL-C levels; improved inflammation; and reduced lipid droplet size in adipose tissue. Further lipidomic analysis of adipose tissue revealed that 31 lipid species are considered to be underlying lipid biomarkers in COS therapy. These lipids are mainly enriched in pathways involving insulin resistance, thermogenesis, cholesterol metabolism, glyceride metabolism and cyclic adenosine monophosphate (cAMP), which sheds light on the weight loss mechanism of COS. The Western blot assay demonstrated that COSM intervention can improve insulin resistance, inhibit de novo synthesis, and promote thermogenesis and & beta;-oxidation in mitochondria by the AMPK pathway, thereby alleviating high-fat diet-induced obesity. In short, our study can provide a more comprehensive direction for the application of COS in obesity based on molecular markers.

学科与关键词

关键词
AMP-activated protein kinasechitooligosaccharideslipidomicsobesity
相关
加载中…
  • Chitosan oligosaccharide activates brown adipose tissue by modulating the gut microbiota and bile acid pathways based on faecal microbiota transplantation
    Lun, Weijun; Zhou, Jingwen; Bai, Yan; Che, Qishi; Cao, Hua; Guo, Jiao*; Su, Zhengquan*Journal of Functional Foods, 2023, 108: 105731.
  • The Ameliorative Effect of COST on Diet-Induced Lipid Metabolism Disorders by Regulating Intestinal Microbiota
    You, Huimin; Deng, Xiaoyi; Bai, Yan; He, Jincan; Cao, Hua; Che, Qishi; Guo, Jiao*; Su, Zhengquan*Marine Drugs, 2022, 20(7): 444.被引 4
  • Marine Chitooligosaccharide Alters Intestinal Flora Structure and Regulates Hepatic Inflammatory Response to Influence Nonalcoholic Fatty Liver Disease
    Feng, Jiayao; Liu, Yongjian; Chen, Jiajia; Bai, Yan; He, Jincan; Cao, Hua; Che, Qishi; Guo, Jiao*; Su, Zhengquan*Marine Drugs, 2022, 20(6): 383.被引 11
查看全部 →

发表信息

论文状态
公开发表
期刊
MOLECULES
发表日期
2023-07
卷期
第 28 卷, 第 14 期
页码
5595
DOI
10.3390/molecules28145595
语言
ENGLISH
成果收录
SCIE
资助标注
Science and Technology Program of Guangzhou, China [202103000089]; Guangdong Demonstration Base for Joint Cultivation of Postgraduates; Science Foundation for Distinguished Young Scholars of Guangdong [2020B1515020026]

作者

  • Z

    Zhou, Minchuan (第一作者)

    guangdong pharmaceut univ · new

  • H

    Huang, Jingqing

    guangdong pharmaceut univ · guilin med univ

查看全部 9 位作者收起作者
  • Z

    Zhou, Jingwen

    guangdong pharmaceut univ · new

  • Z

    Zhi, Cuiting

    guangdong pharmaceut univ

  • B

    Bai, Yan

    guangdong pharmaceut univ

  • C

    Che, Qishi

  • C

    Cao, Hua

    guangdong pharmaceut univ

  • G

    Guo, Jiao (通讯)

    guangdong pharmaceut univ

  • S

    Su, Zhengquan (通讯)

    guangdong pharmaceut univ · new

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417